Leprosy in China

The Lancet Infectious Diseases

Volumn 12, Issue 1, 2012, Pages 11-

  Lun, Zhao Rong ^a,b   Zhu, Xing Quan ^a   Yang, Ting Bao ^b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; MINOCYCLINE; RIFAMPICIN;

ANTIBIOTIC THERAPY; CHINA; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH EDUCATION; INFECTION CONTROL; LEPROSY; LETTER; PATIENT CARE; PRIORITY JOURNAL;

HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE;

EID: 84055192702     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70336-X     Document Type: Letter

References (4)

1. Rodrigues LC, Lockwood DNJ Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis 2011, 11:464-470.
2. Shen JP, Zhang GC, Chen XS, Zhou M, Yu MW, Yan LB A long-term evolution on the epidemiological characteristics of leprosy, towards the goal of its elimination in 1949-2007 in China. Chin J Epidemiol 2008, 29:1095-1100. (in Chinese).
3. Ministry of Health and relevant departments express sympathy and solicitude with leprosy patients Ministry of Health, (accessed July 28, 2011). http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/ptpxw/201101/50510.htm.
4. Alberts CJ, Smith WCA, Meima A, Wang LM, Richardus JH Potential effect of the World Health Organization's 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: a trend analysis. Bull World Health Organ 2011, 89:487-495.